SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd.

SUGP is trending as traders discuss its low float and potential for a short squeeze, drawing comparisons to other Hong Kong-based stocks. Community members are highlighting the company's regained NASDAQ compliance and a substantial contract that exceeds its market capitalization as potential catalysts. High cost to borrow is also fueling speculation.

Recall is a decentralized skill market for AI where communities fund, rank, and discover the AI solutions they need. Instead of corporations pushing one-size-fits-all AI, Recall flips the dynamic—communities signal demand, developers compete to deliver, and performance determines visibility.

Recall

RECALL CRYPTO is trending as traders discuss its recent ICO and potential for high volume gains, with some highlighting its presence on platforms like pump.fun. Community members are expressing bullish sentiment and speculating on short squeeze potential, while also cautioning about the risks associated with new, low-liquidity coins.

Towns

Towns is trending as the community rallies behind its potential, with many expressing excitement for its future. Bullish sentiment is fueled by discussions around its tokenomics, particularly its on-chain matrix structure. Some traders are also moving profits from other tokens into Towns, contributing to the increased attention.

Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.

Solana Co. - Ordinary Shares - Class A

Solana Co

$HSDT is trending due to a planned $500M Solana-backed treasury, with the community actively discussing its potential as a public market $SOL play.  Traders are weighing whether this move signals a game-changer or a potential dilution trap, while also monitoring the stock's volatility and short squeeze possibilities.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending amidst broader crypto market discussions, with community members weighing potential rebounds and comparing it to other cryptocurrencies. Some traders are closely watching pump.fun coins on the Solana network, while others express bullish sentiment and discuss staking strategies. Chatter around memecoins like $UPDOG, $BROKE, and $CAW within the Solana ecosystem is also contributing to the increased attention.

GIGA is a meme token deployed on the Solana blockchain intended to honor the legend Ernest Khalimov the original “Gigachad”, by utilizing the strength of memes and “Chad” energy.  GIGA is a community run project.

GigaChad

GigaChad ($GIGA) is trending as the community rallies around its potential as a leading meme coin, emphasizing its strong culture and dedicated following. Community members frequently mention 'WAGMI' (We're All Gonna Make It) and the potential for significant gains, with some drawing comparisons to other successful meme coins. Discussions also highlight the project's association with fitness and merchandise, suggesting a growing ecosystem.

NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lie Ping Chen in September 2015 and is headquartered in Beltsville, MD.

Nextcure Inc

NXTC is trending due to significant after-hours movement, fueled by new preclinical data related to brittle bone disease. The community is discussing the low float, potential for a squeeze, and upcoming catalysts, while some express concerns about management and past performance. This activity places NXTC within the volatile biotechnology sector, known for its potential for both high gains and significant losses.

JERRY (JYAI) is a Matt Furie's artistic style; it features an AI-powered content creation hub that produces community-driven video series and art.  Jerry the Turtle, created by Matt Furie, is a character inspired by Furie’s artistic style. JERRY is also an AI-driven meme coin with an ambitious vision. The goal is to establish an AI-powered production house dedicated to creating a video series or episodes featuring characters from Matt Furie’s universe alongside those from Jerry’s world.  This unique blend of characters aims to produce the ultimate crypto-based series. Additionally, we are developing an app that will offer an exclusive, ad-free video series featuring characters from both Matt Furie’s creations and the Jerry Universe. Users will be able to download and share videos directly through the platform.  But that’s not all! A special Jerry Art Panel will showcase original Jerry characters, artwork, and fan creations—free to explore, download, and share with the community.

Jerry The Turtle By Matt Furie

Jerry The Turtle ($JYAI) is trending as community members anticipate listings on major exchanges like Kraken and KuCoin, with some claiming fees have already been paid. Bullish sentiment is fueled by comparisons to other successful meme coins like Pepe, Shiba Inu, and Dogwifhat, as well as a billboard advertisement and potential partnerships. The community emphasizes holding ('HODL') and buying dips, while highlighting its strong foundation and potential for significant growth.

Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes aortic stents and stent grafts, surgical sealants, and On-X products. The Preservation Services segment offers cardiac and vascular tissue preservation services. The company was founded on January 19, 1984, and is headquartered in Kennesaw, GA.

Artivion Inc

Artivion ($AORT) is trending due to updated analyst ratings and target price adjustments. Community members are sharing positive write-ups and discussing the company's fundamentals in the medical device sector. Some are also pointing to technical chart patterns as a reason for increased attention.

Spyre Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product, Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency. The company was founded by George Georgiou and David G. Lowe on December 16, 2013 and is headquartered in Waltham, MA.

Spyre Therapeutics Inc.

Aeglea BioTherapeutics Inc

SYRE (Spyre Therapeutics) is trending due to positive analyst coverage and promising clinical trial updates, driving investor optimism. Community discussions revolve around the company's potential leadership in inflammatory bowel disease (IBD) treatment and the value of its pipeline, particularly extended half-life antibodies. Recent Phase 1 results and upcoming Phase 2 readouts are key catalysts, placing SYRE in an active pharmaceutical M&A area.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is It Wise to Buy Coca-Cola Pre-Q3 Earnings Amid Soft Volume Trends?

KO's Q3 results are expected to reflect steady growth, but soft volumes, currency headwinds and rising costs test its pricing power.

CELH Stock Trading Close to 52-Week High: What's the Next Best Move?

CELH stock hovers near a 52-week high as strong sales, brand momentum and Alani Nu gains fuel investor confidence.


PepsiCo Jumps 3.7% After Q3 Earnings: Rally Justified or Overdone?

PEP jumps after reporting strong Q3 results as pricing gains, global demand and innovation fuel bullish investor sentiment.

Celsius Holdings' International Sales Up 27%: What's Next for 2025?

CELH's international sales climb 27% in the second quarter of 2025 as global demand for its drinks continues to grow.


Why Monster Beverage (MNST) is Poised to Beat Earnings Estimates Again

Monster Beverage (MNST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Beverage Industry Shifts: What Coca-Cola Must Do to Stay Ahead

KO is reinventing its portfolio with healthier drinks, bold innovations and digital campaigns to fuel growth.

PepsiCo Sees Momentum Pre-Q3 Earnings: Is This the Right Time to Buy?

PEP's Q3 outlook shows strength in beverages and global markets, but rising costs may pressure margins despite solid execution.

Can MNST Lead the Next Wave of Global Energy Drink Growth?

Monster Beverage delivers more than $2 billion in quarterly revenues, fueling global growth with innovation, marketing power and expanding reach.

Can KDP's Energy Push & Coffee Revival Drive Sustainable Growth?

Keurig Dr Pepper's energy surge and coffee revival fuel momentum. But can innovation secure lasting growth?

Monster Beverage Corp. is a holding company, which engages in the development, marketing, sale, and distribution of energy drink beverages and concentrates. It operates through the following segments: Monster Energy Drinks, Strategic Brands, and Other. The Monster Energy Drinks segment sells ready-to-drink packaged energy drinks to bottlers and full-service beverage distributors. The Strategic Brands segment sells concentrates and beverage bases to authorized bottling and canning operations. The Other segment consists of certain products sold by its subsidiary, American Fruits and Flavors LLC to independent third-party customers. The company was founded on April 25, 1990, and is headquartered in Corona, CA.

Monster Beverage Corp.

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$70.22
Prev Close	$70.16
Open	$70.57
Dividend Yield	0.00%
50-Day Moving Average	$65.17
Beta	0.47
Avg. Volume	5.17M
PE Ratio	43.85

52-Week High	$70.65
52-Week Low	$45.70
Market Capitalization	$68.56B
EPS (Annual)	$1.49
Price to Book	9.53
Revenue Per Employee	$1.14M
Enterprise Value/EBITDA	N/A

MNST
Monster Beverage Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MNST News

MNSTMonster Beverage Corp.